Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joseph Gentile

Orthopaedic Surgery Huntersville, NC Medical Doctor

NPI 1871757724 CMS profile 388152

6909 Prosperity Church Rd, Huntersville, NC 28078

Open in the dashboard

General payments

$49,953

128 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$1,054,884

5 holdings reported · through program year 2025

Through program year 2025, Joseph Gentile of Huntersville, NC is reported in the CMS Open Payments database as having received $49,953 across 128 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $1,054,884 across 5 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,987 16
2024 General $8,592 19
2023 General $6,589 32
2022 General $17,778 22
2021 General $5,726 12
2020 General $371 5
2019 General $4,911 22
2025 Ownership $212,812 1
2023 Ownership $185,736 1
2022 Ownership $292,173 1
2021 Ownership $260,108 1
2020 Ownership $104,055 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Gentile
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Joseph Gentile were reported at $5,987. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Joseph Gentile Orthopaedic Surgery median Middle half National median
2019 $4,911 $644 $140–$2,844 $163
2020 $371 $312 $75–$1,860 $114
2021 $5,726 $520 $117–$2,495 $132
2022 $17,778 $598 $128–$2,731 $149
2023 $6,589 $461 $128–$2,264 $160
2024 $8,592 $497 $134–$2,475 $164
2025 $5,987 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Catalyst OrthoScience $35,572 44 payments
  2. Smith+Nephew, Inc. $5,396 22 payments
  3. Encore Medical, LP $2,234 3 payments
  4. FX Shoulder USA, Inc $1,255 2 payments
  5. Arthrex, Inc. $1,070 16 payments
  6. Zimmer Biomet Holdings, Inc. $1,043 6 payments
  7. Peerless Surgical Inc. $992 6 payments
  8. Exactech, Inc. $935 4 payments
  9. Stryker Corporation $660 9 payments
  10. Medacta USA, Inc. $419 6 payments
  11. Other $377 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $32,977 16 payments
  2. Travel and Lodging $8,234 21 payments
  3. Food and Beverage $7,241 90 payments
  4. Honoraria $1,500 1 payment
Products named General payments · program years 2019–2025
  1. Catalyst Total CSR $19,213 16 payments
  2. Catalyst CSR Shoulder System $7,175 3 payments
  3. Archer CSR Total Shoulder System $4,838 2 payments
  4. Archer R1 Reverse Shoulder System $4,838 2 payments
  5. Bioinductive Implant with Arthroscopic Delivery System - Medium $4,566 17 payments
  6. Mini-Open Latarjet $4,181 13 payments
  7. ENDOBUTTON $2,303 9 payments
  8. DJO Surgical AltiVate Anatomic System $2,234 3 payments
  9. Q-FIX $1,878 4 payments
  10. AETOS Shoulder System $1,878 4 payments
  11. Other $10,732 82 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

75

Median for Orthopedic Surgery: 203

Drug cost

$253

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 19 $119
Tramadol Hcl Generic 43 $106
Meloxicam Generic 13 $28

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$184,467

Of which drugs: $14,957

Medicare patients

399

Average age 74

Services billed

3,212

239 women, 160 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 28%
Depression 25%
Chronic kidney disease 23%
Ischemic heart disease 22%
Atrial fibrillation 17%
COPD 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose J7323 Office 42 138 $12,632
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 168 1,276 $922

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

128 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record